title: From innovation to implementation: optimizing long-term outcomes after TAVR.
authors.affiliation: Division of Cardiology, San Francisco General Hospital, San Francisco, California; Department of Medicine, and the Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, California. Electronic address: kazi@ucsf.edu.
authors.forename: Dhruv S
authors.initials: DS
authors.lastname: Kazi
mesh_terms: D001024:Aortic Valve Stenosis / Q000601:surgery*; D001241:Aspirin; D000077144:Clopidogrel; D005260:Female; D006470:Hemorrhage; D006801:Humans; D008297:Male; D013988:Ticlopidine / Q000031:analogs & derivatives*; D065467:Transcatheter Aortic Valve Replacement / Q000009:adverse effects*
chemical_list: D000077144:Clopidogrel; D013988:Ticlopidine; D001241:Aspirin
keywords: TAVI; bleeding; technology dissemination; transcatheter aortic valve replacement